4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine

C77H95BN22O10 — CID 158768882

IUPAC4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine
SMILESCC(C)n1nnnc1-c1cccc(N)n1.CC1(C)OB(c2cnn(C3CC3)c2)OC1(C)C.CCOC(=O)c1cc(-c2cnn(C3CC3)c2)c(C)cn1.CCOC(=O)c1cc(=O)c(C)c[nH]1.CCOC(=O)c1cc(C)c(C)cn1.Cc1cnc(C(=O)Nc2cccc(-c3nnnn3C(C)C)n2)cc1-c1cnn(C2CC2)c1
InChIInChI=1S/C22H23N9O.C15H17N3O2.C12H19BN2O2.C10H13NO2.C9H12N6.C9H11NO3/c1-13(2)31-21(27-28-29-31)18-5-4-6-20(25-18)26-22(32)19-9-17(14(3)10-23-19)15-11-24-30(12-15)16-7-8-16;1-3-20-15(19)14-6-13(10(2)7-16-14)11-8-17-18(9-11)12-4-5-12;1-11(2)12(3,4)17-13(16-11)9-7-14-15(8-9)10-5-6-10;1-4-13-10(12)9-5-7(2)8(3)6-11-9;1-6(2)15-9(12-13-14-15)7-4-3-5-8(10)11-7;1-3-13-9(12)7-4-8(11)6(2)5-10-7/h4-6,9-13,16H,7-8H2,1-3H3,(H,25,26,32);6-9,12H,3-5H2,1-2H3;7-8,10H,5-6H2,1-4H3;5-6H,4H2,1-3H3;3-6H,1-2H3,(H2,10,11);4-5H,3H2,1-2H3,(H,10,11)
InChIKeyIPPQNXZFOXOKPC-UHFFFAOYSA-N
MW1499.56 g/mol
LogP11.39
Rot. Bonds18

About 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine

4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine (PubChem CID 158768882) has the molecular formula C77H95BN22O10 and a molecular weight of 1499.56 g/mol. Its IUPAC name is 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine.

Molecular Properties

Compound Name4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine
PubChem CID158768882
Molecular FormulaC77H95BN22O10
Molecular Weight1499.56 g/mol
Exact Mass1498.77
IUPAC Name4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine
SMILESCC(C)n1nnnc1-c1cccc(N)n1.CC1(C)OB(c2cnn(C3CC3)c2)OC1(C)C.CCOC(=O)c1cc(-c2cnn(C3CC3)c2)c(C)cn1.CCOC(=O)c1cc(=O)c(C)c[nH]1.CCOC(=O)c1cc(C)c(C)cn1.Cc1cnc(C(=O)Nc2cccc(-c3nnnn3C(C)C)n2)cc1-c1cnn(C2CC2)c1
InChIInChI=1S/C22H23N9O.C15H17N3O2.C12H19BN2O2.C10H13NO2.C9H12N6.C9H11NO3/c1-13(2)31-21(27-28-29-31)18-5-4-6-20(25-18)26-22(32)19-9-17(14(3)10-23-19)15-11-24-30(12-15)16-7-8-16;1-3-20-15(19)14-6-13(10(2)7-16-14)11-8-17-18(9-11)12-4-5-12;1-11(2)12(3,4)17-13(16-11)9-7-14-15(8-9)10-5-6-10;1-4-13-10(12)9-5-7(2)8(3)6-11-9;1-6(2)15-9(12-13-14-15)7-4-3-5-8(10)11-7;1-3-13-9(12)7-4-8(11)6(2)5-10-7/h4-6,9-13,16H,7-8H2,1-3H3,(H,25,26,32);6-9,12H,3-5H2,1-2H3;7-8,10H,5-6H2,1-4H3;5-6H,4H2,1-3H3;3-6H,1-2H3,(H2,10,11);4-5H,3H2,1-2H3,(H,10,11)
InChIKeyIPPQNXZFOXOKPC-UHFFFAOYSA-N
XLogP11.39
TPSA390.45 Ų
H-Bond Donors3
H-Bond Acceptors30
Rotatable Bonds18
Heavy Atoms110
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001499.56
LogP ≤ 511.39
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine?
The IUPAC name of 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine (CID 158768882) is 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine.
What is the SMILES notation for 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine?
The canonical SMILES for 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine is CC(C)n1nnnc1-c1cccc(N)n1.CC1(C)OB(c2cnn(C3CC3)c2)OC1(C)C.CCOC(=O)c1cc(-c2cnn(C3CC3)c2)c(C)cn1.CCOC(=O)c1cc(=O)c(C)c[nH]1.CCOC(=O)c1cc(C)c(C)cn1.Cc1cnc(C(=O)Nc2cccc(-c3nnnn3C(C)C)n2)cc1-c1cnn(C2CC2)c1.
What is the InChIKey of 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine?
The InChIKey is IPPQNXZFOXOKPC-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H23N9O.C15H17N3O2.C12H19BN2O2.C10H13NO2.C9H12N6.C9H11NO3/c1-13(2)31-21(27-28-29-31)18-5-4-6-20(25-18)26-22(32)19-9-17(14(3)10-23-19)15-11-24-30(12-15)16-7-8-16;1-3-20-15(19)14-6-13(10(2)7-16-14)11-8-17-18(9-11)12-4-5-12;1-11(2)12(3,4)17-13(16-11)9-7-14-15(8-9)10-5-6-10;1-4-13-10(12)9-5-7(2)8(3)6-11-9;1-6(2)15-9(12-13-14-15)7-4-3-5-8(10)11-7;1-3-13-9(12)7-4-8(11)6(2)5-10-7/h4-6,9-13,16H,7-8H2,1-3H3,(H,25,26,32);6-9,12H,3-5H2,1-2H3;7-8,10H,5-6H2,1-4H3;5-6H,4H2,1-3H3;3-6H,1-2H3,(H2,10,11);4-5H,3H2,1-2H3,(H,10,11).
What are the key properties of 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine?
4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine has a molecular weight of 1499.56 g/mol, XLogP of 11.39, 18 rotatable bonds, 3 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(1-cyclopropylpyrazol-4-yl)-5-methyl-N-[6-(1-propan-2-yltetrazol-5-yl)-2-pyridinyl]pyridine-2-carboxamide;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;ethyl 4-(1-cyclopropylpyrazol-4-yl)-5-methylpyridine-2-carboxylate;ethyl 4,5-dimethylpyridine-2-carboxylate;ethyl 5-methyl-4-oxo-1H-pyridine-2-carboxylate;6-(1-propan-2-yltetrazol-5-yl)pyridin-2-amine is sourced from PubChem (CID 158768882), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).